Alpha Defensin and 16S rRNA Gene in Diagnosis of PJI
Utility of Alpha Defensin and 16S rRNA Gene in Diagnosis of Prosthetic Joint Infection
1 other identifier
observational
90
1 country
1
Brief Summary
Total joint replacement is considered one of the most successful surgical procedures in the field of orthopedics. Despite this achievement, prosthetic joint infections is still considered a severe complication often leading to catastrophic results and requiring repeated and extensive treatment. The incidence of PJI (a prosthetic joint infection) varies depending on the joint involved; the rate of arthroplasties becoming infected is as follows: 1.7% of primary and 3.2%of non-primary hip arthroplasties. The accurate diagnosis of prosthetic joint infection often involves the combination of multiple factors including symptoms, signs, synovial fluid cell count, serum inflammatory markers, and culture. The sensitivity of synovial fluid culture is only 85%, so a negative culture does not rule out infection. However, the specificity of synovial fluid culture is approximately 95%, and positive cultures often imply the presence of prosthetic joint infection. The synovial fluid alpha-defensin test is an immunoassay that was specifically developed to aid in the diagnosis of prosthetic joint infection . The sensitivity and the specificity of the alpha-defensin immunoassay test have been reported to be above 96%. Molecular diagnostic tests using polymerase chain reaction (PCR) are emerging as a tool for the diagnosis of infections and noninfectious conditions. The application of PCR techniques with primers derived from the highly conserved regions of the bacterial 16S rRNA gene has been useful in the detection of bacterial organisms. Use of broad-range 16S rRNA gene PCR as a tool for identification of bacteria is possible because the 16S rRNA gene is present in all bacteria . Aim of the work: .Determine sensitivity and specificity of alpha defensing and 16S rRNA gene in diagnosis of prosthetic joint infection.
- Detection of antibiotic sensitivity for different organisms isolated from synovial fluid
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2018
CompletedFirst Posted
Study publicly available on registry
October 22, 2018
CompletedStudy Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2020
CompletedOctober 22, 2018
October 1, 2018
1 year
October 18, 2018
October 18, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Diagnostic value of Alpha defensin in diagnosis of Prosthetic joint infection
value of measuring Alpha defensin by enzyme linked immunosorbent assay (ELISA) in diagnosis of Prosthetic joint infection as a rapid bio marker
2 days
Diagnostic value of 16S rRNA gene in diagnosis of Prosthetic joint infection
value of measuring 16S rRNA gene by conventional PCR in diagnosis of Prosthetic joint infection as more accurate test
2 days
Interventions
Alpha defensin 16S rRNA gene CBC: Complete blood count CRP: C reactive protein ESR: Erythrocyte sedimentation rate Culture and antibiotic sensitivity of synovial fluid
Eligibility Criteria
This study will be conducted on 90 informed individuals (according to guidelines of ethical committee of faculty of medicine , Assuit University )
You may qualify if:
- \- The study will include all patient with prosthetic joint suspected to be infected through clinical manifestation (fever, pain, fistula redness, swelling ,hotness and loss of function) associated with radiological evidence.
You may not qualify if:
- Any patient began antibiotic treatment will be excludes from the samples.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ayat Bakhet Mostafa
Asyut, Egypt
Related Publications (2)
Slullitel PA, Onativia JI, Buttaro MA, Sanchez ML, Comba F, Zanotti G, Piccaluga F. State-of-the-art diagnosis and surgical treatment of acute peri-prosthetic joint infection following primary total hip arthroplasty. EFORT Open Rev. 2018 Jul 17;3(7):434-441. doi: 10.1302/2058-5241.3.170032. eCollection 2018 Jul.
PMID: 30233819BACKGROUNDDudareva M, Barrett L, Figtree M, Scarborough M, Watanabe M, Newnham R, Wallis R, Oakley S, Kendrick B, Stubbs D, McNally MA, Bejon P, Atkins BA, Taylor A, Brent AJ. Sonication versus Tissue Sampling for Diagnosis of Prosthetic Joint and Other Orthopedic Device-Related Infections. J Clin Microbiol. 2018 Nov 27;56(12):e00688-18. doi: 10.1128/JCM.00688-18. Print 2018 Dec.
PMID: 30209185BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Osama Bakr Sedek, MD
Assuit Univeristy
- STUDY CHAIR
Dalia Tarik Kamal, MD
Assuit Univeristy
- STUDY CHAIR
Amal Mohammed Hosney, MD
Assuit Univeristy
- STUDY DIRECTOR
Ayat Bakhet Mostafa, Dr
Assuit Univeristy
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctor
Study Record Dates
First Submitted
October 18, 2018
First Posted
October 22, 2018
Study Start
January 1, 2019
Primary Completion
January 1, 2020
Study Completion
January 1, 2020
Last Updated
October 22, 2018
Record last verified: 2018-10